Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Bioactive Compounds

Items 8361-8370 of 13616

Page
per page
  1. Oxaliplatin
    A8648 Oxaliplatin
     12 Citation
    Summary: platinum-based chemotherapeutic agent
      insoluble in EtOH; ≥3.94 mg/mL
  2. CNX-2006
    B3227 CNX-2006
    Summary: mutant-EGFR inhibitor, selective and irreversible
      ≥27.3 mg/mL
  3. Amyloid Beta-Peptide (12-28) (human)
    A1123 Amyloid Beta-Peptide (12-28) (human)
    Summary: sequence H2N-VHHQKLVFFAEDVGSNK-OH
      ≥195.5 mg/mL
  4. BAY-598
    B6081 BAY-598
    Summary: SMYD2 inhibitor
      Soluble in DMSO
  5. Picolinamide
    B6150 Picolinamide
    Summary: poly (ADP-ribose) synthetase inhibitor
      ≥83.33 mg/mL
  6. MRT68921
    B6174 MRT68921
    Summary: dual autophagy kinase ULK1/2 inhibitor
      insoluble in H2O; insoluble in EtOH; ≥2.18 mg/mL
  7. CPI-637
    B7801 CPI-637
    Summary: CBP/EP300 bromodomain inhibitor
      insoluble in EtOH; insoluble in H2O; ≥19.3 mg/mL
  8. Phthalazinone pyrazole
    C3823 Phthalazinone pyrazole
    Summary: Aurora A kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥7.14 mg/mL
  9. 6-Aminonicotinamide
    C4497 6-Aminonicotinamide
    Summary: 6-phosphogluconate dehydrogenase inhibitor
      insoluble in H2O; insoluble in EtOH; ≥13.7 mg/mL
  10. bpV(HOpic) (potassium salt, technical grade)
    C4614 bpV(HOpic) (potassium salt, technical grade)
    Summary: protein tyrosine phosphatases (PTPs) inhibitor
      insoluble in EtOH; insoluble in DMSO; ≥90.4 mg/mL

Items 8361-8370 of 13616

Page
per page